All News Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-05-06 am EDT			5-day change	1st Jan Change
156 ^INR	+3.28%		+8.86%	+12.35%

Apr. 27	Piramal Pharma Limited Receives Assessment Orders from the Office of the Navi Mumbai Municipal Corporation, Cess Department	CI
Apr. 19	Piramal Pharma Limited Receives Order from the Regional Provident Fund Commissioner, Thane South, Levying Damages of INR 1,120,932 Under Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piramal Pharma Limited Receives Assessment Orders from the Office of the Navi Mumbai Municipal Corporation, Cess Department	Apr. 27	CI
Piramal Pharma Limited Receives Order from the Regional Provident Fund Commissioner, Thane South, Levying Damages of INR 1,120,932 Under Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996	Apr. 19	CI
Piramal Pharma Gets US FDA's Establishment Inspection Report for Riverview, US Facility	Apr. 17	MT
Piramal Pharma Forays into Men Grooming Products	Apr. 10	MT
Piramal Pharma Limited Announces the Launch of BOHEM Product Range	Apr. 10	CI
Transcript : Piramal Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024	Jan. 31
Piramal Pharma Turns to Profit in Fiscal Q3	Jan. 31	MT
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024	Jan. 30	AQ
Piramal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 30	CI
PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND	Dec. 18	AQ
Piramal Pharma Solutions Commences Opening of Its Antibody-Drug Conjugate Manufacturing Expansion in Grangemouth, Scotland	Dec. 18	CI
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China	Nov. 26	RE
Piramal Pharma Gets US FDA's EIR Report After Bethlehem, USA Unit Inspection	Nov. 09	MT
Jefferies Adjusts Piramal Pharma's Price Target to INR135 From INR125, Keeps at Buy	23-10-31	MT
Piramal Pharma Swings to Profit in Fiscal Q2	23-10-30	MT
Transcript : Piramal Pharma Limited, Q2 2024 Earnings Call, Oct 30, 2023	23-10-29
Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024	23-10-28	AQ
Piramal Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-27	CI
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities At Ahmedabad Discovery Services Site	23-10-16	CI
Piramal Pharma Gets Two Observations from US FDA After Inspection of US Facility	23-09-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

All News

Filters